These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11392040

  • 1. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z.
    Cas Lek Cesk; 2001 Apr 26; 140(8):234-7. PubMed ID: 11392040
    [Abstract] [Full Text] [Related]

  • 2. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z, Haas T.
    Vnitr Lek; 2003 Jul 26; 49(7):535-40. PubMed ID: 12931435
    [Abstract] [Full Text] [Related]

  • 3. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec 26; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 4. [Changes in serum levels of IGF-I and its binding proteins and their relation to microcirculation in obese patients].
    Krsek M, Prázný M, Sucharda P, Marek J, Justová V, Lacinová Z.
    Vnitr Lek; 2001 Dec 26; 47(12):847-51. PubMed ID: 11826548
    [Abstract] [Full Text] [Related]

  • 5. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr 26; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 6. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun 26; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 7. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J, Prázný M, Kvasnicka J, Kalvodová B.
    Cas Lek Cesk; 2001 Jun 21; 140(12):370-4. PubMed ID: 11503186
    [Abstract] [Full Text] [Related]

  • 8. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jun 21; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 21; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factors and their binding proteins in children with IDDM.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2002 Jan 21; 85(1):41-52. PubMed ID: 12075719
    [Abstract] [Full Text] [Related]

  • 11. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F.
    Eur Cytokine Netw; 2006 Sep 21; 17(3):167-74. PubMed ID: 17194636
    [Abstract] [Full Text] [Related]

  • 12. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug 21; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 13. Inverse changes in fetal insulin-like growth factor (IGF)-1 and IGF binding protein-1 in association with higher birth weight in maternal diabetes.
    Lindsay RS, Westgate JA, Beattie J, Pattison NS, Gamble G, Mildenhall LF, Breier BH, Johnstone FD.
    Clin Endocrinol (Oxf); 2007 Mar 21; 66(3):322-8. PubMed ID: 17302863
    [Abstract] [Full Text] [Related]

  • 14. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes.
    Capoluongo E, Pitocco D, Lulli P, Minucci A, Santonocito C, Manto A, Di Stasio E, Zaccardi F, Zuppi C, Ghirlanda G, Ameglio F.
    Cytokine; 2006 Jun 21; 34(5-6):303-11. PubMed ID: 16887362
    [Abstract] [Full Text] [Related]

  • 15. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ.
    J Diabetes Complications; 2005 Jun 21; 19(5):297-304. PubMed ID: 16112506
    [Abstract] [Full Text] [Related]

  • 16. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM.
    Diabetes Metab; 2009 Jun 21; 35(3):198-205. PubMed ID: 19297224
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug 21; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 18. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
    Krsek M, Skrha J, Sucharda P, Justová V, Lacinová Z.
    Cas Lek Cesk; 2003 Aug 21; 142(4):216-9. PubMed ID: 12841123
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.
    Exp Clin Endocrinol Diabetes; 2006 Jul 21; 114(7):371-6. PubMed ID: 16915540
    [Abstract] [Full Text] [Related]

  • 20. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May 21; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.